Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Maybe You Need Some More Testosterone Over There | Main | GSK and Sirtris: A Bit More »

January 22, 2010

Receptors, Moving and Shaking

Email This Entry

Posted by Derek

I've written here before about how I used to think that I understood G-protein coupled receptors (GPCRs), but that time and experience have proven to me that I didn't know much of anything. One of the factors that's complicated that field is the realization that these receptors can interact with each other, forming dimers (or perhaps even larger assemblies) which presumably are there for some good reason, and can act differently from the classic monomeric form.
M1%20receptors.jpg
A neat paper has appeared in PNAS that gives us some quantitative numbers on this phenomenon, and some great pictures as well. What you're looking at is a good ol' CHO cell, transfected with muscarinic M1 receptors. Twenty years ago (gulp) I was cranking out compounds to tickle cell membranes of this exact type, among others. The receptors are visualized by a fluorescent ligand (telenzepine), and the existence of dimers can be inferred by the "double-intensity" spots shown in the inset.

With this kind of resolution and time scale, the UK team that did this work could watch the receptors wandering over the cell surface in real time. It's a classic random walk, as far as they can tell. Watching the cohort of high-intensity spots, they can see changes as they switch to lower-intensity monomers and back again. Over a two-second period, it appeared that about 81% of the tracks were monomers, 9% were dimers, and 3% changed over during the tracking. (The remaining 7% were impossible to assign with confidence, which makes me wonder what's lurking down there).

They refined the technique by using two differently-fluorescent forms of labeled telenzepine, labeling the cells in a 50/50 ratio, and watching what happens to the red, green, (and combined yellow) spots over time. It looks as if the receptor population is a steady-state mix of monomers and dimers, exchanging on a time scale of seconds. Of course, the question comes up of how different ligands might affect this process, and you could begin to answer that with different fluorescent species. But since the technique depends on having a low-off-rate species bound to the receptor in order to see it, some of the most interesting dynamic questions will have to wait. It's still very nice to actually see these things, though; it gives a medicinal chemist something to picture. . .

Comments (7) + TrackBacks (0) | Category: Biological News


COMMENTS

1. trisynthon on January 22, 2010 5:33 PM writes...

Anyone who is as intrigued as I am by this real-time single molecule imaging stuff should check out the review by Sunny Xie: Annu. Rev. Biophys. 2008. 37:417–44. It's an absolute tour de force. This work ain't bad either.

Permalink to Comment

2. leftscienceawhileago on January 22, 2010 11:08 PM writes...

Derek doesn't mention that they have free movies in the supporting info! Nothing like a movie to give you a real feel for what you are looking at.

Permalink to Comment

3. Sili on January 23, 2010 10:09 AM writes...

It's probably not a good sign that I have never heard of Chinese Hamster Ovaries ...

Permalink to Comment

4. Yggdrasil on January 23, 2010 8:17 PM writes...

Perhaps some of the interesting dynamics studies won't have to wait so long. Chemists have developed some methods to covalently label tagged proteins in living cells with "handles" (e.g. biotin, azide groups) to which organic dyes can be attached (for example, see Alice Ting's work on her biotin ligase and lipoic acid ligase systems).

Assuming that these methods can achieve high enough labeling densities and there aren't significant problems with receptor turnover, these technologies could enable these same types of experiments on receptors in their apo or agonist-bound forms.

Permalink to Comment

5. dr.umesh on January 24, 2010 1:07 AM writes...

I like the way, u cover the topics and more over I was happy to see your lines...

"it's our ignorance that gives me room for optimism"
(Chemistry World - Column: In the pipeline)

I agree with ur optimism. Though lots of serendipity is adding to the drug discovery, so hoping to see the rapid growth in the field of drug discovery in the days to come....

Permalink to Comment

6. Jose on January 24, 2010 11:32 PM writes...

Optimism? Really? The fact that so much biologically crucial complexity (suspected but wholly under-appreciated) lurks in a *really* well studied receptor class puts some serious weight behind the "low-hanging fruit" school of thought about the drop off in drug approvals.

Permalink to Comment

7. smurf on January 25, 2010 1:13 AM writes...

Have not read the paper yet, but key is to proof that the interaction between the receptors is not just an artefact related to the overexpression of the receptors in CHO cells.

Would be interesting to repeat the experiment e.g. with Bladder Smooth Muscle cells.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
A Last Summer Day Off
The Early FDA
Drug Repurposing
The Smallest Drugs
Life Is Too Short For Some Journal Feeds
A New Look at Phenotypic Screening
Small Molecules - Really, Really Small
InterMune Bought